SADAFCO program highlights importance of milk

The program will run until the end of April and aims to reach at least 500,000 girls and boys.
Updated 22 April 2019

SADAFCO program highlights importance of milk

Saudia Dairy and Foodstuff Company (SADAFCO) recently launched a Kingdom-wide awareness program across public and private schools. The program aims to educate students about the importance of milk as an easy and nutritious solution to support their active lifestyles and nurture growth.

Under the slogan “Healthy Eating Equals Better Health,” SADAFCO will collaborate with trained educators who will visit primary schools to talk about the importance of milk for children’s health and bodies. The program will run until the end of April and aims to reach at least 500,000 girls and boys.

“We acknowledge the nutritional challenges children commonly face, especially in the Middle East, where obesity rates are reported to be more than 50 percent,” said Gabriel Predescu, marketing manager at SADAFCO. “Students in primary schools are generally very active and as a result, their nutritional needs are very high. That’s why, at SADAFCO, we believe that this program will be instrumental in demonstrating the importance of milk in a healthy balanced diet and allow the kids of today to contribute to the development of this great nation.”

In order to encourage students to participate in the program, SADAFCO is also holding an online competition, where the students draw the benefits of drinking milk and share their drawings on social media. Fifty winners will be rewarded with new bicycles from SADAFCO. 

“Milk is recognized as being one of the most nutritious liquid foods available. It contains 14 out of the 18 nutrients humans need, including vitamins, proteins, fats, sugars and carbohydrates,” said Sara Alshehri, event and social media manager at SADAFCO. “We made sure to deliver the message to the students using their language and in an entertaining manner to boost healthy habits among them.”

SADAFCO is a publicly listed company producing dairy and foodstuff products under the Saudia brand name since 1977, a year after the company was formed. Saudia enjoys being one of the market leaders in the Kingdom in the production of tomato paste, ice cream and milk.

Based in Jeddah, SADAFCO operates sales and distribution depots in 24 locations across Saudi Arabia, Bahrain, Jordan and Kuwait. Saudia products are also exported to several countries in the MENA region.


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.